Skip to content
  • Careers
  • Login to WCG IRB Connexus
WCG IRB logo Toggle Menu
  • Services
      • IRB Review ServicesFor more than 50 years, we’ve set the standard for IRB review through service, expertise, and innovation.
      • IBC Administration & ReviewSince 2000, we’ve provided Institutional Biosafety Committee services to nearly 800 institutions in 14 countries.
      • Leading Technology Supporting Ethical Review
      • Expanded Access / Compassionate Use
      • Independent Review Services
      • Services For
      • Institutions
      • Investigators
      • Sponsors & CROs
      • Research Participants
  • How to Submit
      • How to Submit for IRB Review
      • Download IRB Forms
      • Request a Fee Schedule
      • How to Submit for IBC Review
      • Download IBC Forms
      • Resources
      • Download Resources
      • Frequently Asked Questions
      • Login to WCG IRB Connexus
  • Insights
    • Ethical Review Insights
    • Ask the IRB and IBC Experts
    • Case Studies
    • News & Events
    • COVID-19 Resource Center
    • WCG Institute
    • WCG Podcast
  • About Us
    • About WCG IRB
    • Leadership & Advisory Boards
    • International Fellows Program
    • Compliance Statement
    • IRB Registration & FWA
    • News & Events
    • Careers
  • Contact Us

Blog Posts Insights

Viewing all entries for: Blog Posts

  • Insights
    • Insights Archive
      • Blog Posts
Blog Posts

Managing the Shortage of Contrast Agents in Clinical Research Studies

Read More about Managing the Shortage of Contrast Agents in Clinical Research Studies
Blog Posts

WCG IRB’s Single-Patient Expanded Access Experience Before and During the COVID-19 Pandemic

Read More about WCG IRB’s Single-Patient Expanded Access Experience Before and During the COVID-19 Pandemic
Blog Posts

Using an IRB’s Site Relationships to Relieve “Site Crunch” and Reduce Trial Pressures

Read More about Using an IRB’s Site Relationships to Relieve “Site Crunch” and Reduce Trial Pressures
guidance documentation Blog Posts

Key Takeaways From FDA’s New Draft Guidance, “Studying Multiple Versions of a Cellular or Gene Therapy Product in an Early-Phase Clinical Trial”

Read More about Key Takeaways From FDA’s New Draft Guidance, “Studying Multiple Versions of a Cellular or Gene Therapy Product in an Early-Phase Clinical Trial”
Woman in doctor's office reviewing form with female doctor. Blog Posts

Compensating Research Participants FAQ

Read More about Compensating Research Participants FAQ
Blog Posts

Four Key Elements You Need to Know About the Role of IBCs in Gene Therapy Trials

Read More about Four Key Elements You Need to Know About the Role of IBCs in Gene Therapy Trials
Elderly Patient with mask Blog Posts

Single-Patient Expanded Access: WCG IRB Expands Dedication and Experience in 2020

Read More about Single-Patient Expanded Access: WCG IRB Expands Dedication and Experience in 2020
  • Content Type
    • Ask the Experts
    • Blog Posts
    • Case Studies
    • News & Events
    • Videos
    • Whitepapers

Tags

  • adverse events
  • advertising
  • assent form
  • biosafety
  • centralized review
  • challenge studies
  • child subjects
  • COI
  • common rule
  • compensation
  • consent
  • coverage analysis
  • covid-19
  • data
  • decentralized
  • deviations
  • Diversity
  • e-consent
  • eligibility
  • ethics
  • expanded access
  • fda review
  • gene therapy
  • gene transfer
  • hipaa
  • human factors
  • IBC
  • incentives
  • infectious disease
  • informed consent
  • investigational
  • IRB Review
  • LGBTQIA+
  • medical devices
  • observational studies
  • oncology
  • patient screening
  • payments
  • pragmatic clinical trials
  • privacy
  • protocol deviations
  • recruitment
  • reimbursement
  • remote assessment
  • reporting
  • staffing
  • stem cells
  • training
  • translations
  • vaccine
  • virtual trials
Viewing 1 - 7 of 7 articles
  • WCG Privacy Policy
  • WCG Terms of Use
  • Sitemap
  • Do Not Sell My Information
  • Log4j Status Updates

Copyright 2022 WCG IRB. All rights reserved.